SMS Pharmaceuticals · NSE: SMSPHARMA · BSE: 532815
Q2 FY19 results · Jul–Sep 2018
SMS Pharmaceuticals reported revenue from operations of ₹134.84 crore and net profit of ₹12.56 crore for Q2 FY19 (Jul–Sep 2018), on a standalone basis.
| Item | Q2 FY19 | Q2 FY18 | YoY | Q1 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 134.84 | — | — | 125.11 | +7.8% |
| Other income | 1.49 | — | — | 0.36 | +311.2% |
| Total income | 136.33 | — | — | 125.47 | +8.7% |
| Profit before tax | 19.04 | — | — | 16.29 | +16.9% |
| Net profit for the period | 12.56 | — | — | 10.11 | +24.2% |
| EPS, basic (₹) | 1.48 | — | — | 1.19 | +24.4% |
| Net margin (%) | 9.3 | — | 8.1 |
Standalone
- Filed with BSE
- 12 Nov 2018, 16:22 IST
- Board meeting
- 10 Nov 2018
- Period
- 01 Jul 2018 to 30 Sep 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE